Comprehending the intricate interplay among SUSD4, JAK/STAT signaling, and colorectal cancer prognosis offers potential for identifying novel therapeutic targets and devising personalized treatment strategies for patients. This evidence concerns the gene SOAT1 and colorectal cancer.